![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Thiem, Alexander; Mashhadiakbar, Pegah; Cussigh, Christiane; Hassel, Jessica C.; Grimmelmann, Imke; Gutzmer, Ralf; Schlaak, Max; Heppt, Markus V.; Duecker, Pia; Huening, Svea; Schulmeyer, Lena; Schilling, Bastian; Haferkamp, Sebastian; Ziemer, Mirjana; Moritz, Rose K. C.; Hagelstein, Victoria; Terheyden, Patrick; Posch, Christian; Gaiser, Maria R.; Kropp, Peter; Emmert, Steffen; Mueller, Britta und Tietze, Julia K.
(2022):
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 37, Nr. 5: S. 884-893
Heppt, Markus V.; Letule, Valerie; Laniauskaite, Ieva; Reinholz, Markus; Tietze, Julia K.; Wolff, Hans; Ruzicka, Thomas und Sattler, Elke C.
(2018):
Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center.
In: Facial Plastic Surgery, Bd. 34, Nr. 1: S. 88-94
Heppt, Markus V.; Roesch, Alexander; Weide, Benjamin; Gutzmer, Ralf; Meier, Friedegund; Loquai, Carmen; Kähler, Katharina C.; Gesierich, Anja; Meissner, Markus; Bubnoff, Dagmar von; Göppner, Daniela; Schlaak, Max; Pföhler, Claudia; Utikal, Jochen; Heinzerling, Lucie; Cosgarea, Ioana; Engel, Jutta; Eckel, Renate; Martens, Alexander; Mirlach, Laura; Satzger, Imke; Schubert-Fritschle, Gabriele; Tietze, Julia K. und Berking, Carola
(2017):
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
In: European Journal of Cancer, Bd. 81: S. 36-44
Heppt, Markus V.; Goldscheider, Ilana; Tietze, Julia K. und Berking, Carola
(2017):
Intralesional interleukin-2 for unresectable mucosal melanoma refractory to nivolumab.
In: Cancer Immunology Immunotherapy, Bd. 66, Nr. 10: S. 1377-1378
Heppt, Markus V.; Heinzerling, Lucie; Kähler, Katharina C.; Forschner, Andrea; Kirchberger, Michael C.; Loquai, Carmen; Meissner, Markus; Meier, Friedegund; Terheyden, Patrick; Schell, Beatrice; Herbst, Rudolf; Göppner, Daniela; Kiecker, Felix; Rafei-Shamsabadi, David; Haferkamp, Sebastian; Huber, Margit A.; Utikal, Jochen; Ziemer, Mirjana; Bumeder, Irmgard; Pfeiffer, Christiane; Schäd, Susanne G.; Schmid-Tannwald, Christoph; Tietze, Julia K.; Eigentler, Thomas K. und Berking, Carola
(2017):
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
In: European Journal of Cancer, Bd. 82: S. 56-65
Tietze, Julia K.; Angelova, Daniela; Heppt, Markus V.; Ruzicka, Thomas und Berking, Carola
(2017):
Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy.
In: Experimental Dermatology, Bd. 26, Nr. 7: S. 622-629
Hassel, Jessica C.; Heinzerling, Lucie; Aberle, Jens; Bähr, Oliver; Eigentler, Thomas K.; Grimm, Marc-Oliver; Grünwald, Victor; Leipe, Jan; Reinmuth, Niels; Tietze, Julia K.; Trojan, Jörg; Zimmer, Lisa und Gutzmer, Ralf
(2017):
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions.
In: Cancer Treatment Reviews, Bd. 57: S. 36-49
[PDF, 559kB]
Tietze, Julia K.; Angelova, Daniela; Heppt, Markus V.; Reinholz, Markus; Murphy, William J.; Spannagl, Michäl; Ruzicka, Thomas und Berking, Carola
(2017):
The proportion of circulating CD45RO(+)CD8(+) memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab.
In: European Journal of Cancer, Bd. 75: S. 268-279
Zimmer, Lisa; Goldinger, Simone M.; Hofmann, Lars; Loquai, Carmen; Ugurel, Selma; Thomas, Ioannis; Schmidgen, Maria I.; Gutzmer, Ralf; Utikal, Jochen S.; Göppner, Daniela; Hassel, Jessica C.; Meier, Friedegund; Tietze, Julia K.; Forschner, Andrea; Weishaupt, Carsten; Leverkus, Martin; Wahl, Renate; Dietrich, Ursula; Garbe, Claus; Kirchberger, Michael C.; Eigentler, Thomas; Berking, Carola; Gesierich, Anja; Krackhardt, Angela M.; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard und Heinzerling, Lucie M.
(2016):
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.
In: European Journal of Cancer, Bd. 60: S. 210-225
Hofmann, Lars; Forschner, Andrea; Loquai, Carmen; Goldinger, Simone M.; Zimmer, Lisa; Ugurel, Selma; Schmidgen, Maria I.; Gutzmer, Ralf; Utikal, Jochen S.; Göppner, Daniela; Hassel, Jessica C.; Meier, Friedegund; Tietze, Julia K.; Thomas, Ioannis; Weishaupt, Carsten; Leverkus, Martin; Wahl, Renate; Dietrich, Ursula; Garbe, Claus; Kirchberger, Michael C.; Eigentler, Thomas; Berking, Carola; Gesierich, Anja; Krackhardt, Angela M.; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard und Heinzerling, Lucie M.
(2016):
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy.
In: European Journal of Cancer, Bd. 60: S. 190-209
Heppt, Markus V.; Dietrich, Cecilia; Graf, Saskia A.; Ruzicka, Thomas; Tietze, Julia K. und Berking, Carola
(2016):
The Systemic Management of Advanced Melanoma in 2016.
In: Oncology Research and Treatment, Bd. 39, Nr. 10: S. 635-642
[PDF, 539kB]
Gerdes, Lisa Ann; Held, Kathrin; Beltrán, Eduardo; Berking, Carola; Prinz, Jörg C.; Junker, Andreas; Tietze, Julia K.; Ertl-Wagner, Birgit; Straube, Andreas; Kümpfel, Tania; Dornmair, Klaus und Hohlfeld, Reinhard
(2016):
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
In: Annals of Neurology, Bd. 80, Nr. 2: S. 294-300
Heppt, Markus V.; Eigentler, Thomas K.; Kähler, Katharina C.; Herbst, Rudolf A.; Göppner, Daniela; Gambichler, Thilo; Ulrich, Jens; Dippel, Edgar; Loquai, Carmen; Schell, Beatrice; Schilling, Bastian; Schäd, Susanne G.; Schultz, Erwin S.; Matheis, Fanny; Tietze, Julia K. und Berking, Carola
(2016):
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.
In: Cancer Immunology Immunotherapy, Bd. 65, Nr. 8: S. 951-959